{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:20:05Z","timestamp":1790698805674,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2-3","license":[{"start":{"date-parts":[[2013,4,11]],"date-time":"2013-04-11T00:00:00Z","timestamp":1365638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,4,11]],"date-time":"2013-04-11T00:00:00Z","timestamp":1365638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s12026-013-8400-4","type":"journal-article","created":{"date-parts":[[2013,4,10]],"date-time":"2013-04-10T14:39:39Z","timestamp":1365604779000},"page":"299-303","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Adverse events following immunization with vaccines containing adjuvants"],"prefix":"10.1007","volume":"56","author":[{"given":"S.","family":"Cerpa-Cruz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Paredes-Casillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Landeros Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. G.","family":"Bernard-Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Mart\u00ednez-Bonilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Guti\u00e9rrez-Ure\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,11]]},"reference":[{"issue":"12","key":"8400_CR1","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1248\/yakushi.131.1723","volume":"131","author":"T Nakayama","year":"2011","unstructured":"Nakayama T. Influenza vaccine and adjuvant. Yakugaku Zasshi. 2011;131(12):1723\u201331.","journal-title":"Yakugaku Zasshi"},{"issue":"5","key":"8400_CR2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1586\/14760584.6.5.673","volume":"6","author":"M Kwissa","year":"2007","unstructured":"Kwissa M, Kasturi SP, Pulendran B. The science of adjuvants. Expert Rev Vaccines. 2007;6(5):673\u201384.","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"8400_CR3","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/BOR.0b013e32835448b8","volume":"24","author":"P Cruz-Tapias","year":"2012","unstructured":"Cruz-Tapias P, et al. Infections and vaccines in the etiology of antiphospholipid syndrome. Curr Opin Rheumatol. 2012;24(4):389\u201393.","journal-title":"Curr Opin Rheumatol"},{"issue":"64","key":"8400_CR4","first-page":"195","volume":"12","author":"M de Veer","year":"2011","unstructured":"de Veer M, Meeusen E. New developments in vaccine research\u2014unveiling the secret of vaccine adjuvants. Discov Med. 2011;12(64):195\u2013204.","journal-title":"Discov Med"},{"issue":"6","key":"8400_CR5","doi-asserted-by":"publisher","first-page":"565","DOI":"10.2217\/imt.12.43","volume":"4","author":"WW Leitner","year":"2012","unstructured":"Leitner WW. Vaccine adjuvants: is the pipeline clogged? Immunotherapy. 2012;4(6):565\u20137.","journal-title":"Immunotherapy"},{"issue":"4","key":"8400_CR6","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1586\/erv.11.21","volume":"10","author":"VE Schijns","year":"2011","unstructured":"Schijns VE, Lavelle EC. Trends in vaccine adjuvants. Expert Rev Vaccines. 2011;10(4):539\u201350.","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"8400_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jaut.2010.07.003","volume":"36","author":"Y Shoenfeld","year":"2011","unstructured":"Shoenfeld Y, Agmon-Levin N. \u2018ASIA\u2019 - autoimmune\/inflammatory syndrome induced by adjuvants. J Autoimmun. 2011;36(1):4\u20138.","journal-title":"J Autoimmun"},{"key":"8400_CR8","unstructured":"WHO. Surveillance of adverse events following immunization. Field guide for managers of immunization programmes. Geneva. 1997."},{"key":"8400_CR9","unstructured":"WHO. Supplementary information on vaccine safety. Part 2. Background rates of adverse events following immunization. Geneva. 2000."},{"issue":"7","key":"8400_CR10","doi-asserted-by":"publisher","first-page":"e40745","DOI":"10.1371\/journal.pone.0040745","volume":"7","author":"J Vitoriano-Souza","year":"2012","unstructured":"Vitoriano-Souza J, et al. Cell recruitment and cytokines in skin mice sensitized with the vaccine adjuvants: saponin, incomplete Freund\u2019s adjuvant, and monophosphoryl lipid A. PLoS One. 2012;7(7):e40745.","journal-title":"PLoS One"},{"key":"8400_CR11","doi-asserted-by":"crossref","unstructured":"Levy O, Goriely S, Kollmann TR. Immune response to vaccine adjuvants during the first year of life. Vaccine. 2012.","DOI":"10.1016\/j.vaccine.2012.10.016"},{"key":"8400_CR12","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1177\/0961203311429550","volume":"21","author":"A Katzav","year":"2012","unstructured":"Katzav A, Kivity S, Blank M, Shoenfeld Y, Chapman J. Adjuvant immunization induces high levels of pathogenic antiphospholipid antibodies in genetically prone mice: another facet of the ASIA syndrome. Lupus. 2012;21:210\u20136.","journal-title":"Lupus"},{"issue":"2","key":"8400_CR13","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1177\/0961203311430090","volume":"21","author":"A Lerner","year":"2012","unstructured":"Lerner A. Aluminum as an adjuvant in Crohn\u2019s disease induction. Lupus. 2012;21(2):231\u20138.","journal-title":"Lupus"},{"issue":"2","key":"8400_CR14","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1177\/0961203311429318","volume":"21","author":"Y Zafrir","year":"2012","unstructured":"Zafrir Y, et al. Autoimmunity following hepatitis B vaccine as part of the spectrum of \u2018Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants\u2019 (ASIA): analysis of 93 cases. Lupus. 2012;21(2):146\u201352.","journal-title":"Lupus"},{"issue":"2","key":"8400_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1177\/0961203311429817","volume":"21","author":"K Perdan-Pirkmajer","year":"2012","unstructured":"Perdan-Pirkmajer K, et al. Autoimmune response following influenza vaccination in patients with autoimmune inflammatory rheumatic disease. Lupus. 2012;21(2):175\u201383.","journal-title":"Lupus"},{"issue":"38","key":"8400_CR16","doi-asserted-by":"publisher","first-page":"6592","DOI":"10.1016\/j.vaccine.2011.06.112","volume":"29","author":"P Ray","year":"2011","unstructured":"Ray P, et al. Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15\u201359\u00a0years of age. Vaccine. 2011;29(38):6592\u20137.","journal-title":"Vaccine"},{"issue":"2","key":"8400_CR17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1177\/0961203311430221","volume":"21","author":"L Tomljenovic","year":"2012","unstructured":"Tomljenovic L, Shaw CA. Mechanisms of aluminum adjuvant toxicity and autoimmunity in pediatric populations. Lupus. 2012;21(2):223\u201330.","journal-title":"Lupus"},{"issue":"9","key":"8400_CR18","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.jinorgbio.2005.04.021","volume":"99","author":"WJ Lukiw","year":"2005","unstructured":"Lukiw WJ, Percy ME, Kruck TP. Nanomolar aluminum induces pro-inflammatory and pro-apoptotic gene expression in human brain cells in primary culture. J Inorg Biochem. 2005;99(9):1895\u20138.","journal-title":"J Inorg Biochem"},{"issue":"7198","key":"8400_CR19","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/nature06939","volume":"453","author":"SC Eisenbarth","year":"2008","unstructured":"Eisenbarth SC, et al. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature. 2008;453(7198):1122\u20136.","journal-title":"Nature"},{"issue":"2","key":"8400_CR20","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1177\/0961203311429557","volume":"21","author":"RK Gherardi","year":"2012","unstructured":"Gherardi RK, Authier FJ. Macrophagic myofasciitis: characterization and pathophysiology. Lupus. 2012;21(2):184\u20139.","journal-title":"Lupus"},{"issue":"2","key":"8400_CR21","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1177\/0961203311429316","volume":"21","author":"N Agmon-Levin","year":"2012","unstructured":"Agmon-Levin N, Hughes GR, Shoenfeld Y. The spectrum of ASIA: \u2018Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants\u2019. Lupus. 2012;21(2):118\u201320.","journal-title":"Lupus"},{"issue":"3","key":"8400_CR22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.it.2009.12.009","volume":"31","author":"C Exley","year":"2010","unstructured":"Exley C, Siesjo P, Eriksson H. The immunobiology of aluminium adjuvants: how do they really work? Trends Immunol. 2010;31(3):103\u20139.","journal-title":"Trends Immunol"},{"issue":"2","key":"8400_CR23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/0961203311429818","volume":"21","author":"M Whitehouse","year":"2012","unstructured":"Whitehouse M. Oily adjuvants and autoimmunity: now time for reconsideration? Lupus. 2012;21(2):217\u201322.","journal-title":"Lupus"},{"issue":"2","key":"8400_CR24","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1177\/0961203311430090","volume":"21","author":"A Lerner","year":"2012","unstructured":"Lerner A. Aluminum as an adjuvant in Crohn\u2019s disease induction. Lupus. 2012;21(2):231\u20138.","journal-title":"Lupus"},{"issue":"1","key":"8400_CR25","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/jpepsy\/jsr048","volume":"37","author":"JP Barile","year":"2012","unstructured":"Barile JP, et al. Thimerosal exposure in early life and neuropsychological outcomes 7\u201310\u00a0years later. J Pediatr Psychol. 2012;37(1):106\u201318.","journal-title":"J Pediatr Psychol"},{"issue":"1","key":"8400_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1556\/AMicr.52.2005.1.5","volume":"52","author":"A Madi","year":"2005","unstructured":"Madi A. Being on the track of thimerosal. Review. Acta Microbiol Immunol Hung. 2005;52(1):95\u2013103.","journal-title":"Acta Microbiol Immunol Hung"},{"issue":"2","key":"8400_CR27","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/toxsci\/kfr009","volume":"120","author":"L Barregard","year":"2011","unstructured":"Barregard L, et al. Toxicokinetics of mercury after long-term repeated exposure to thimerosal-containing vaccine. Toxicol Sci. 2011;120(2):499\u2013506.","journal-title":"Toxicol Sci"},{"issue":"2","key":"8400_CR28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1177\/0961203311430222","volume":"21","author":"A Soriano","year":"2012","unstructured":"Soriano A, et al. Giant cell arteritis and polymyalgia rheumatica after influenza vaccination: report of 10 cases and review of the literature. Lupus. 2012;21(2):153\u20137.","journal-title":"Lupus"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-013-8400-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-013-8400-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-013-8400-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-013-8400-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T10:44:27Z","timestamp":1659091467000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-013-8400-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,11]]},"references-count":28,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["8400"],"URL":"https:\/\/doi.org\/10.1007\/s12026-013-8400-4","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,11]]},"assertion":[{"value":"11 April 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}